BETAAccess all features while we're in beta! Some features may become paid later.Send feedback →
vpside

RKDA

Arcadia Biosciences, Inc.
Nasdaq · Crude petroleum & natural gas (SIC 1311) · FY ends 31 Dec

Revenue, quarterly

$1M−0.8% year on year
$4M$2M$0
Q3 ’21Q4 ’22Q1 ’24Q1 ’25Q2 ’26
Company filings · 10-Q filed 13 Aug 2026 · Q4 = FY − 9Mvpside.com

Gross margin, trailing twelve months

34.6%−3.2 pp year on year
100%50%0%−50%
Q3 ’21Q4 ’22Q1 ’24Q1 ’25Q2 ’26
Company filings · 10-Q filed 13 Aug 2026 · TTM = last four quartersvpside.com

Cash and cash equivalents, quarter-end

$4M+203.6% year on year
$40M$20M$0
Q3 ’21Q4 ’22Q1 ’24Q1 ’25Q2 ’26
Company filings · 10-Q filed 13 Aug 2026 · balance sheet, period-endvpside.com

Free cash flow, trailing twelve months

−$5M
$10M$0−$10M−$20M−$30M
Q1 ’21Q2 ’22Q3 ’23Q3 ’24Q4 ’25
Company filings · 10-Q filed 13 Aug 2026 · TTM = last four quartersvpside.com
Chart 05 is empty
Chart 06 is empty